INDP - Indaptus Therapeutics, Inc.
0.825
0.015 1.818%
Share volume: 14,481
Last Updated: 03-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.81
0.01
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-08-2024 | 08-12-2024 | 11-12-2024 | |
| Cash flow financing | 316.047 K | 38.064 K | 2.592 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | |
| Cash flow | -3.620 M | 0.000 | 0.000 | |
| Net income | -3.807 M | -4.015 M | -3.069 M | |
| Depreciation | 735.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | |
| Cash Change | -3.620 M | -2.440 M | 78.935 K |